GlassScriptPhysician profile
Ghyath A Samman
NPI 1912012352
$10,892.12
in general payments reported to CMS, 2019-2025
40 companies · $564 in 2025
The $564 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,028 · 2020: $477 · 2021: $1,097 · 2022: $991 · 2023: $1,807 · 2024: $3,928 · 2025: $564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,086 · Food and Beverage: $2,931 · Long Term Medical Supply Or Device Loan: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,086.47 |
| Food and Beverage | $2,930.90 |
| Long Term Medical Supply Or Device Loan | $281.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,235.99 | 2019-2025 | Versacross Access Solution, Ekosonic, Acuity Steerable |
| Abbott Laboratories | $1,919.23 | 2019-2025 | Portico, Dragonfly Opstar, Cardiomems |
| Medtronic, INC. | $1,576.25 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Venaseal |
| Baylis Medical Company INC | $483.51 | 2021 | |
| Novartis Pharmaceuticals Corporation | $350.20 | 2019-2025 | |
| Pfizer INC. | $338.47 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $330.59 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $320.01 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $241.77 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $241.21 | 2021-2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $231.15 | 2019-2024 | Eliquis, Camzyos |
| Amgen INC. | $184.13 | 2019-2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $181.07 | 2019-2023 | Jardiance |
| Philips North America LLC | $121.36 | 2022 | |
| Medtronic Vascular, INC. | $113.73 | 2019 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $89.62 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Inari Medical, INC. | $76.68 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiva Medical, INC. | $69.41 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Esperion Therapeutics, INC. | $68.96 | 2021-2024 | Nexletol |
| Impulse Dynamics (USA) INC. | $66.49 | 2022-2023 | Optimizer |
| Imperative Care, INC | $57.67 | 2025 | Prodigy Catheter |
| Angiodynamics, INC. | $48.56 | 2024 | Alphavac |
| Avinger INC. | $43.80 | 2021 | |
| Bardy Diagnostics, INC. | $43.09 | 2019-2020 | |
| Irhythm Technologies, INC. | $42.99 | 2019-2023 | Zio Xt Patch |
| Regeneron Healthcare Solutions, INC. | $42.73 | 2019 | |
| Abiomed | $41.73 | 2020-2023 | Impella |
| Thrombolex, INC. | $40.58 | 2025 | Bashir Endovascular Catheter |
| Kestra Medical Technology Services, INC. | $37.46 | 2024-2025 | Assure Wcd |
| Bard Peripheral Vascular, INC. | $36.96 | 2025 | Rotarexs 6 F X 135 Cm |
| Novo Nordisk INC | $27.99 | 2024 | |
| Elutia, INC. | $27.70 | 2019-2021 | |
| Akcea Therapeutics, INC. | $26.94 | 2020 | |
| Tactile Systems Technology INC | $23.29 | 2024 | Entre Plus, Flexitouch Plus |
| Scpharmaceuticals INC. | $21.38 | 2025 | |
| Cvrx, INC. | $21.02 | 2023 | Barostim Neo System |
| Cardiovascular Systems INC. | $20.65 | 2021 | |
| Sanofi-Aventis U.S. LLC | $19.60 | 2022 | |
| Sirtex Medical INC | $15.15 | 2024 | Lava Les (Liquid Embolic System) |
| Biotronik INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ghyath Samman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.